Improvement was defined as a decrease in the HbA1c level by more than 0.5% without strengthening the therapy for DM (i. e., starting diabetes medication, increasing the insulin injection dose, adding new oral hypoglycemic agents, or switching from oral hypoglycemic agents to insulin injection) compared with the condition before the initiation n of CST. Here, INS is linked to diabetes mellitus.